Nabeel Nabulsi Selected Research

AS2471907

10/2021

Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nabeel Nabulsi Research Topics

Disease

8	Alcoholism (Alcohol Abuse) 01/2022 - 03/2013
5	Mental Disorders (Mental Disorder) 01/2022 - 08/2013
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 09/2011
4	Wounds and Injuries (Trauma) 10/2021 - 09/2011
4	Schizophrenia (Dementia Praecox) 01/2020 - 02/2010
3	Obesity 01/2021 - 02/2014
3	Cognitive Dysfunction 01/2020 - 01/2016
3	Substance-Related Disorders (Drug Abuse) 12/2019 - 03/2013
3	Cocaine-Related Disorders (Cocaine Addiction) 01/2019 - 01/2010
2	Tobacco Use Disorder (Nicotine Dependence) 10/2022 - 01/2018
2	Pain (Aches) 01/2022 - 01/2016
2	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 07/2017
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 10/2015
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2020
2	Anxiety Disorders (Anxiety Disorder) 01/2017 - 03/2013
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Insulin Resistance 01/2020
1	Necrosis 01/2020
1	Neoplasms (Cancer) 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Hyperglycemia 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Seizures (Absence Seizure) 02/2016
1	Brain Diseases (Brain Disorder) 10/2014
1	Neuroinflammatory Diseases 10/2013
1	Mood Disorders (Mood Disorder) 04/2013
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2011

Drug/Important Bio-Agent (IBA)

8	Dopamine (Intropin)FDA LinkGeneric 10/2022 - 04/2015
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2013
5	Glutamic Acid (Glutamate)FDA Link 11/2020 - 08/2013
5	Metabotropic Glutamate 5 ReceptorIBA 11/2020 - 08/2013
4	kappa Opioid Receptors (kappa Opioid Receptor)IBA 01/2022 - 03/2013
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	Opioid Receptors (Opioid Receptor)IBA 12/2018 - 04/2013
3	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 12/2019
3	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 02/2010
3	EnzymesIBA 10/2021 - 01/2016
2	Nicotine FDA Link 10/2022 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2021 - 01/2020
2	GlucocorticoidsIBA 10/2021 - 01/2017
2	naxagolideIBA 01/2021 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 08/2019
2	Pharmaceutical PreparationsIBA 04/2015 - 05/2011
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 02/2014 - 01/2010
2	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2014 - 08/2013
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	2- (2- (dimethylaminomethylphenylthio))- 5- fluoromethylphenylamineIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 10/2021
1	AS2471907IBA 10/2021
1	Cocaine (Cocaine HCl)IBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 01/2020
1	GSK215083IBA 01/2020
1	serotonin 6 receptorIBA 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 12/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 12/2019
1	Dynorphins (Dynorphin)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2017
1	Dopamine D3 ReceptorsIBA 10/2016
1	cariprazineIBA 10/2016
1	LigandsIBA 10/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2016
1	Type 2 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016
1	CytokinesIBA 10/2015
1	CarbonIBA 04/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 04/2015
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 05/2011

Therapy/Procedure

1	Immunotherapy 01/2020
1	Therapeutics 12/2019
1	Drug Therapy (Chemotherapy) 01/2017